Peptide directoryHeart, vessels & kidneys

Angiotensin IV

A six-residue angiotensin that sharpens memory in rats.

Where it comes from

Made in
Made from angiotensin III by aminopeptidase N, in brain, kidney and vessels
Sent out by
Follows the shorter angiotensins
Acts on
  • Hippocampus
  • Kidney vessels
  • Endothelium

What it does

  • Improves learning and memory when given into the brain of a rat 2
  • Raised kidney cortical blood flow in rats, though later work reports the opposite
  • Raises PAI-1 in endothelium, which is the one effect with a plausible route to thrombosis

In medicine

  • No medicine and no test. Its binding site turned out to be an enzyme rather than a classical receptor, which changed how the whole AT4 literature is read 1
  • Because IRAP sits inside the cell and trims other peptides too, what an angiotensin IV analogue actually does is harder to state than for a receptor drug 1
  • It is not measured in practice: these fragments are too short-lived and too close in mass for a routine assay

Beyond the body’s own use

  • Given into the brain of a rat it improves spatial learning, and the effect has held up across laboratories. That is the whole basis of the memory claim 2
  • IRAP inhibitors and angiotensin IV analogues are studied for memory loss in animals. None has reached a human trial, and no medicine has come of it 1
  • The reported effect on kidney blood flow has gone both ways in different rat studies, which is a fair warning about how firm any of this is

Sources

  1. Albiston et al., Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin-regulated aminopeptidase, Journal of Biological Chemistry 2001
  2. Wright et al., Contributions of the brain angiotensin IV-AT4 receptor system to spatial learning, Journal of Neuroscience 1999

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.